Your browser doesn't support javascript.
loading
Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study.
Niewczas, Monika A; Sirich, Tammy L; Mathew, Anna V; Skupien, Jan; Mohney, Robert P; Warram, James H; Smiles, Adam; Huang, Xiaoping; Walker, Walker; Byun, Jaeman; Karoly, Edward D; Kensicki, Elizabeth M; Berry, Gerard T; Bonventre, Joseph V; Pennathur, Subramaniam; Meyer, Timothy W; Krolewski, Andrzej S.
Afiliación
  • Niewczas MA; 1] Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, Massachussetts, USA [2] Department of Medicine, Harvard Medical School, Boston, Massachussetts, USA.
  • Sirich TL; Renal Division, Department of Medicine, Stanford School of Medicine, Stanford, California, USA.
  • Mathew AV; Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Skupien J; 1] Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, Massachussetts, USA [2] Department of Medicine, Harvard Medical School, Boston, Massachussetts, USA [3] Department of Metabolic Diseases, Jagiellonian University, Krakow, Poland.
  • Mohney RP; Metabolon Inc, Durham, North Carolina, USA.
  • Warram JH; 1] Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, Massachussetts, USA [2] Department of Medicine, Harvard Medical School, Boston, Massachussetts, USA.
  • Smiles A; Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, Massachussetts, USA.
  • Huang X; Metabolism Program, Boston Childrens Hospital, Boston, Massachussetts, USA.
  • Walker W; Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, Massachussetts, USA.
  • Byun J; Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Karoly ED; Metabolon Inc, Durham, North Carolina, USA.
  • Kensicki EM; Metabolon Inc, Durham, North Carolina, USA.
  • Berry GT; 1] Department of Medicine, Harvard Medical School, Boston, Massachussetts, USA [2] Metabolism Program, Boston Childrens Hospital, Boston, Massachussetts, USA.
  • Bonventre JV; 1] Department of Medicine, Harvard Medical School, Boston, Massachussetts, USA [2] Renal Division, Brigham and Women's Hospital, Boston, Massachussetts, USA.
  • Pennathur S; Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Meyer TW; Renal Division, Department of Medicine, Stanford School of Medicine, Stanford, California, USA.
  • Krolewski AS; 1] Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, Massachussetts, USA [2] Department of Medicine, Harvard Medical School, Boston, Massachussetts, USA.
Kidney Int ; 85(5): 1214-24, 2014 May.
Article en En | MEDLINE | ID: mdl-24429397

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Uremia / Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Metabolómica / Aminoácidos Esenciales / Fallo Renal Crónico Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Kidney Int Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Uremia / Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Metabolómica / Aminoácidos Esenciales / Fallo Renal Crónico Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Kidney Int Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
...